To test efficacy of tranexamic acid in the control of bleeding in patients vomiting blood and passing blood in stools.

Phase 2

• Conditions: Health Condition 1: K922- Gastrointestinal hemorrhage, unspecified

• Registration Number: CTRI/2024/01/061840
• Lead Sponsor: Jawaharlal Institute of Postgraduate Medical Education and Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 4 March 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

all patients aged above 18 years with ugi bleed

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CONTROL OF BLEEDINGTimepoint: At baseline and then every 12th hourly for 5 days

Secondary Outcome Measures

Name	Time	Method
Reducing the incidence of early re-bleeding (uptill 72 hours) <br/ ><br> <br/ ><br> Decreasing in the length of ICU and <br/ ><br> <br/ ><br> Decreasing in the in-hospital mortality rateTimepoint: 5 DAYS